Green Cross Corp. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
47,073
92,055
113,316
117,197
171,861
106,744
Total Accounts Receivable
257,229
256,073
288,630
345,131
368,209
391,504
Inventories
250,016
298,396
324,731
320,753
381,267
386,925
Other Current Assets
6,633
16,357
16,784
18,297
5,199
8,257
Total Current Assets
560,951
662,881
743,462
801,377
926,537
893,430
Net Property, Plant & Equipment
368,127
408,864
500,403
554,026
552,004
559,660
Total Investments and Advances
122,897
195,461
93,242
101,876
111,357
135,877
Long-Term Note Receivable
-
-
-
50
50
21,828
Intangible Assets
44,926
54,632
60,226
73,613
87,917
100,841
Other Assets
6,634
7,852
8,197
8,086
14,811
5,364
Total Assets
1,104,265
1,330,351
1,415,128
1,550,615
1,703,582
1,723,410
ST Debt & Current Portion LT Debt
27,706
122,456
58,686
99,300
5,994
Accounts Payable
100,215
120,390
131,367
118,265
158,803
Income Tax Payable
13,125
20,517
35,140
7,260
10,289
Other Current Liabilities
67,939
71,007
82,542
78,472
84,969
Total Current Liabilities
208,984
334,370
307,735
303,297
260,055
Long-Term Debt
20,590
38,025
74,000
149,545
306,989
Provision for Risks & Charges
21,022
21,163
18,016
20,414
14,218
Deferred Taxes
5,468
7,600
7,673
9,330
8,627
Other Liabilities
8,063
7,904
15,748
16,092
11,327
Total Liabilities
264,856
409,725
417,424
491,604
594,869
Common Equity (Total)
823,101
892,662
956,809
993,071
1,040,213
Total Shareholders' Equity
823,101
892,662
956,809
993,071
1,040,213
Total Equity
839,409
920,627
997,704
1,059,011
1,108,713
Liabilities & Shareholders' Equity
1,104,265
1,330,351
1,415,128
1,550,615
1,703,582
Accumulated Minority Interest
16,307
27,965
40,895
65,940
68,500

About Green Cross

View Profile
Address
107 Ihyeon-ro 30beon-gil
Yongin-si GY 16924
Korea, Republic Of
Employees -
Website http://www.greencross.com
Updated 07/08/2019
Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood products, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin-si, South Korea.